Penumbra, Inc. (PEN) es una empresa que cotiza en bolsa en el Salud sector, operando dentro de la Medical - Devices industria. La empresa tiene su sede en Alameda, CA, United States. El CEO actual es Adam Elsesser.
PEN tiene fecha de IPO 2015-09-18, 4,500 empleados a tiempo completo, cotiza en el NYSE, una capitalización de mercado de $13.04B.
Penumbra, Inc. is a medical device company headquartered in Alameda, California, that designs, develops, manufactures, and markets innovative vascular intervention and neurosurgical products globally. The company specializes in aspiration-based thrombectomy systems for mechanical clot removal, neurovascular embolization coiling systems for treating aneurysms, and neurovascular access systems, marketed under brands including Penumbra System, Penumbra Coil, and Neuron. Its product portfolio also encompasses neurosurgical aspiration tools, peripheral embolization devices, microcatheters, and occlusion devices, along with immersive technology solutions for patient rehabilitation. Penumbra distributes its products through direct sales teams and distributor networks to serve the interventional neuroradiology, neurosurgery, and vascular surgery markets worldwide.
